Comparison of the effects of EM-652 (SCH
β
Matthieu Gutman; Steeve Couillard; Jenny Roy; Fernand Labrie; Bernard Candas; Cl
π
Article
π
2002
π
John Wiley and Sons
π
French
β 182 KB
## Abstract EMβ652 exerts pure antiestrogenic activity in the mammary gland and endometrium, while tamoxifen, the antiestrogen most widely used for the treatment of breast cancer, exerts mixed antiestrogenicβestrogenic activity in these tissues. Our objective was to compare the agonistic and antago